4.6 Article

Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach

Journal

INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 286, Issue -, Pages 214-219

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2019.01.039

Keywords

Cardiovascular disease; Cigarette smoking; Obesity; Diabetes; Dyslipidemia; Hypertension

Funding

  1. Ministry of Health of the Czech Republic [15-27109A]

Ask authors/readers for more resources

Cardiovascular disease (CVD) is the leading cause of death in women in developed countries. The traditional modifiable risk factors are able to explain the majority of CVD mortality. The aim of this review is to analyze gender-specific aspects of major conventional cardiovascular risk factors and to assess whether they have the same impact on CVD in women. Cigarette smoking remains the single largest preventable cause of cardiovascular morbidity and premature death worldwide. Women smoke less than men; however, smoking seems to be more harmful in women, particularly in oral contraceptive users. Obesity in the general population is more prevalent in women. Visceral adiposity is associated with insulin resistance and a higher risk of developing cardiovascular disease. Life expectancy in female diabetic patients is shorter than in men with diabetes; women with diabetes are also at higher risk of developing cardiovascular events. Changes of main lipid parameters in women are frequently associated with their hormonal status and/or hormonal treatment. Hypertension is highly prevalent in post-menopausal women and carries a higher risk of developing left ventricular hypertrophy, which, together with a greater increase in vascular and myocardial stiffness, results in a higher incidence of heart failure with preserved ejection fraction and a higher risk of developing stroke. The risk of abdominal aortic rupture is substantially higher in women. In conclusion, smoking, diabetes and hypertension seem to be more harmful in women. Therefore, the question is whether there should not be lower thresholds for initiating drug treatment in women with diabetes and hypertension. (C) 2019 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Substance Abuse

Weight Concerns Associated With Delay in Quit Date But Not Treatment Outcomes: A Czech Republic Experience

Alexandra Pankova, Eva Kralikova, Lenka Stepankova, Kamila Zvolska, Zbynek Bortlicek, Milan Blaha, Matthew M. Clark, Darrell R. Schroeder, Ivana T. Croghan

NICOTINE & TOBACCO RESEARCH (2018)

Article Medicine, General & Internal

Early weight gain after stopping smoking: a predictor of overall large weight gain? A single-site retrospective cohort study

Alexandra Pankova, Eva Kralikova, Kamila Zvolska, Lenka Stepankova, Milan Blaha, Petra Ovesna, Paul Aveyard

BMJ OPEN (2018)

Article Public, Environmental & Occupational Health

FCTC IMPLEMENTATION: THE ROLE OF STATE OR NON-GOVERNMENT ORGANIZATIONS? AN EXAMPLE OF THE CZECH REPUBLIC

Keely G. Fraser, Alexandra Pankova, Kamila Zvolska, Eva Kralikova

CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH (2019)

Article Engineering, Biomedical

SNPs within CHRNA5-A3-B4 and CYP2A6/B6, nicotine metabolite concentrations and nicotine dependence treatment success in smokers

Jaroslav A. Hubacek, Ivana Kurcova, Vera Maresova, Alexandra Pankova, Lenka Stepankova, Kamila Zvolska, Vera Lanska, Eva Kralikova

Summary: The study analyzed the impact of smoking-related polymorphisms on plasma values of nicotine metabolites, finding significant associations between certain genetic variants and specific metabolite ratios. However, these associations were not directly linked to nicotine abstinence rates.

BIOMEDICAL PAPERS-OLOMOUC (2021)

Article Substance Abuse

Comparison between success rates for smokers re-treated by a smokers' clinic and success rates for smokers treated for the first time

Lenka Stepankova, Eva Kralikova, Kamila Zvolska, Alexandra Pankova, Zuzana Adamcekova, Matyas Kuhn, Derek Noland

Summary: In Prague, Czech Republic, smokers attending stop-smoking treatment more than 2 years after their previous quit attempt achieve similar success rates to first-time treated smokers.

ADDICTION (2021)

Review Substance Abuse

A narrative review of facilitators and barriers to smoking cessation and tobacco-dependence treatment in patients with tuberculosis in low- and middle-income countries

Kamila Zvolska, Alexandra Pankova, Iveta Nohavova, Rumana Huque, Helen Elsey, Melanie Boeckmann, Aziz Sheikh, Kamran Siddiqi, Eva Kralikova

TOBACCO INDUCED DISEASES (2020)

Article Public, Environmental & Occupational Health

HOSPITAL AS A SMOKE-FREE WORKPLACE

Lenka Stepankova, Lenka Kostelecka, Veronika Stejskalova, Milena Kalvachova, Eva Kralikova

CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH (2020)

Article Public, Environmental & Occupational Health

BARRIERS TO INTRODUCTION OF SMOKE-FREE WORKPLACES IN CENTRAL EUROPE: EXAMPLE OF THE CZECH REPUBLIC

Eva Kralikova, Alexandra Pankova

CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH (2020)

Article Medicine, General & Internal

Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial

Jinshuo Li, Steve Parrott, Ada Keding, Omara Dogar, Rhian Gabe, Anna-Marie Marshall, Rumana Huque, Deepa Barua, Razia Fatima, Amina Khan, Raana Zahid, Sonia Mansoor, Daniel Kotz, Melanie Boeckmann, Helen Elsey, Eva Kralikova, Anne Readshaw, Aziz Sheikh, Kamran Siddiqi

Summary: In low-income and middle-income countries, adding cytisine to brief behavioural support does not provide cost-effectiveness for smoking cessation in patients with newly diagnosed pulmonary tuberculosis.

BMJ OPEN (2022)

Article Substance Abuse

Building capacity in tobacco control by establishing the Eastern Europe Nurses' Center of Excellence for Tobacco Control

Stella A. Bialous, Iveta Nohavova, Eva Kralikova, Marjorie J. Wells, Jenny Brook, Linda Sarna

TOBACCO PREVENTION & CESSATION (2020)

Article Public, Environmental & Occupational Health

Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

Omara Dogar, Ada Keding, Rhian Gabe, Anna-Marie Marshall, Rumana Huque, Deepa Barua, Razia Fatima, Amina Khan, Raana Zahid, Sonia Mansoor, Daniel Kotz, Melanie Boeckmann, Helen Elsey, Eva Kralikova, Steve Parrott, Jinshuo Li, Anne Readshaw, Aziz Sheikh, Kamran Siddiqi

LANCET GLOBAL HEALTH (2020)

Article Substance Abuse

Forms of Smoking Among Children Ages 8 to 12Years in Prague, Czech Republic

Jarmila Kucerova, Jiri Rames, Keely Fraser, Eva Kralikova

JOURNAL OF CHILD & ADOLESCENT SUBSTANCE ABUSE (2018)

Article Medical Laboratory Technology

Fecal zonulin is elevated in Crohn's disease and in cigarette smokers

Karin Malickova, Irena Francova, Milan Lukas, Martin Kolar, Eva Kralikova, Martin Bortlik, Dana Duricova, Lenka Stepankova, Kamila Zvolska, Alexandra Pankova, Tomas Zima

PRACTICAL LABORATORY MEDICINE (2017)

Meeting Abstract Cardiac & Cardiovascular Systems

THE MOST EFFECTIVE INTERVENTION TO LOWER ATHEROSCLEROSIS PROGRESSION: TREATMENT OF TOBACCO DEPENDENCE

Kamila Zvolska, Eva Kralikova, Alexandra Pankova, Lenka Stepankova

ATHEROSCLEROSIS (2017)

No Data Available